Please assess the completion status of the following clinical trial:

Trial Title: Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Statut ASA I-III.~* Patient scheduled for anterior crutiate ligament reconstruction under general anesthesia.~Exclusion Criteria:~* Pregnancy.~* Contraindication to local anesthesia.~* Patient with chronic pain, opioid consumption or alcohol consumption.~* Patient with coagulation trouble, hepatic dysfunction or renal dysfunction.~* Patient with diabetic or femoral neuropathy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IPACK block (Type: EXPERIMENTAL): Saphenous nerve block and IPACK block by anesthetist under ultrasound guidance.
- Local infiltration analgesia (Type: ACTIVE_COMPARATOR): Periarticular infiltration by surgeon

Based on this trial design, predict the completion outcome and termination type (if applicable).